Editors' Note: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Siegler JE, Galetta S. Neurology 2022;99:258.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Siegler JE, Galetta S. Editors' Note: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Neurology 2022;99:258.
PMID: 35940889